Objectives: We aimed to investigate the safety of radiofrequency (RF)-renal denervation (RDN) on branch renal arteries (RAs) in a porcine model.
remains unclear. As the diameter of the branch RA is smaller than that of the main RA, there is a potential risk of disruption or stenosis.
Moreover, as branch RA are located adjacent to the kidney, there is a risk of renal damage and impairment of renal function. As prior animal studies of branch RF-RDN were largely focused on its efficacy, the safety of RF-RDN on the branch RA has not been fully investigated. 7, 11 Thus, the aim of the present study was to investigate the safety of RF-RDN on branch RA in a porcine model at 7, 30, and 90 days.
2 | METHODS
| RDN system
The IberisBloom RDN system (Terumo Corporation, Tokyo, Japan)
used in the present study consists of a helical multi-electrode catheter and a multi-channel generator, as previously described. 25 The generator delivers RF (with 6 W for 60 sec) to selected electrodes simultaneously. The IberisBloom system has an automatic algorithm that decreases output power by 1 W in the channel when the corresponding electrode temperature is ≥70 C for 1 sec.
| Animals
All animal procedures were approved by the Institutional Animal Care and Use Committee before study conduct. Table 1 and a 6F guide catheter was advanced to approach the RAs. Intraarterial nitroglycerin (200 μg) was administered before angiography.
Following quantitative vessel analysis (QVA), branch and main RA with diameters of 3-8 mm were treated. Treatment in the branch RA was limited to the outside of the renal parenchyma (hilum) as observed on fluoroscopy, following the protocol from recent clinical studies including branch RA treatment. 4, 8 At termination, treated animals underwent follow-up renal angiography after nitroglycerin administration (200 μg intra-arterial).
A midline laparotomy was performed under general anesthesia in all animals to gain access to the kidneys. Samples of renal cortical tissues were removed from six sites (cranial, middle, and caudal area of the dorsal and ventral aspects of the kidney) per kidney for bioanalysis of norepinephrine concentration. A gross necropsy was performed on animals immediately following euthanasia. After perfusion fixation, RAs with surrounding tissues were harvested en bloc and immersed in 10% neutral-buffered formalin.
| Histopathology
Histological sections were produced at 3-to 5-mm intervals of the treated RA with surrounding tissues, as previously described, 26 and stained 
| Biophysical parameters
The generator automatically measured biophysical parameters (output power, impedance, and electrode temperature) in real time during delivery of RF, as previously described. 25 Relative impedance 
| Renal norepinephrine concentration
Renal cortical tissue samples were immediately frozen by liquid nitrogen and stored at −80 C until bioanalysis. The tissue was homogenized, and the homogenate then analyzed by liquid chromatography with tandem mass spectrometry. Concentrations from each of the six sites from each kidney were then used to calculate the average per kidney.
| Statistical analysis
Data are presented as mean AE standard deviation. QVA and histopathological data were compared by unpaired t test between the main and branch RA. Renal norepinephrine concentration for each treated group was compared with those from the untreated group using the Dunnet test. A one-way analysis of variance (ANOVA) was used to examine differences in serum creatinine change from baseline to terminal across the groups. All statistical analyses were performed with statistical software (GraphPad Prism 7; GraphPad Software, San Diego, CA, USA). A P-value <0.05 was considered to indicate statistical significance.
3 | RESULTS
| In-life observations, serum chemistry, and necropsy
All animals survived until scheduled necropsy without any abnormalities caused by the RDN, as determined by daily clinical observation.
There were no significant differences in serum creatinine change from baseline to terminal between the groups (0.0 AE 0.1 mg/dL in the untreated group, 0.0 AE 0.2, 0.3 AE 0.2, and 0.2 AE 0.3 mg/dL at 7, 30, and 90 days, respectively, in the treated groups; P = 0.15 for all). For gross necropsy, all tissues were normal with the exception of one incidental renal cyst, which is a common spontaneous lesion observed in swine (incidence 6.3%). 27 
| Procedural and angiographic outcomes
The mean baseline lumen diameter of the branch RA was significantly smaller than those of the main RA ( Figure 1 ). The number of ablations per animal was 14.8 AE 2.6 in the 7-day group, 14.5 AE 2.4 in the 30-day group, and 17.5 AE 4.8 in the 90-day group. While luminal irregularities known as "notches" were frequently observed just after treatment, no angiographic abnormalities were observed in the main or branch RA at 7, 30, and 90 days after treatment (Figure 2 ). QVA indicated that the late lumen loss and diameter stenosis were minimal in the main and branch RA at 7, 30, and 90 days (Figure 1 ).
| Histopathology
Treated arterial lumens were almost completely covered by endothelial cells at 7 days, and completely covered at 30 and 90 days, in both the main and branch RA (Table 2, Figure 3 ). The treated media was hyalinized and thinned with smooth muscle cell loss at 7 days, while treated media showed fibrosis instead of hyalinization and thinning at 30 and 90 days (Table 2, Figure 3 ). Neointima, which formed over the
(C) FIGURE 1 Baseline lumen diameter (A) of the main and branch RAs in each group. Late lumen loss (B) and percent diameter stenosis (C) based on follow-up QVA at each time point. Baseline lumen diameter of the main RA was larger than that of the branch RA at alltime points. Late lumen loss and diameter stenosis were overall minimal at all-time points. Although there were statistically significant differences between the main and branch RA at 90 days, they were minimal and of minor clinical significance healed treated media, was minimal at all time points (Figure 3 ). Medial damage and minimal neointimal formation were common to the main and branch RA, and no augmentation was found in the branch RA compared with the main RA. Damage in surrounding tissues including the kidneys, ureters, lymph nodes, and muscles were none or minimal at all time points in both the main and branch RA, while mild necrosis/ inflammation was noted in adipose tissues at 7 days (Table 2) Figure 4B ). The renal parenchyma (renal tubules and glomeruli) was normal beneath the fibrosis area.
| Biophysical parameters
The biophysical parameters are summarized in Table 3 . 
| Effects of branch treatment on RAs
Histopathological changes after RF-RDN on the main RA were previously reported in porcine models. [20] [21] [22] 28 In support of previous data, 22 we found that endothelial cells covered the treated luminal surface almost completely at 7 days in both the main and branch RA. Sakakura et al. reported that medial thinning and hypocellularity (loss of smooth muscle cells) in the main RA were most evident at 7 days, and then resolved at later time points (30, 60, and 180 days). 22 Rippy et al. 28 also described healing of medial damage (evident as fibrosis) at 6 months after RF-RDN on the main RA. In this study, the chronological transition of RF-induced medial damage in both the main and branch RA was consistent with that reported in earlier porcine studies in the main RA. The study by Rippy et al. also reported minimal neointimal thickening composed of several cell layers at 6 months after RF-RDN. 28 Similarly, in the present study the neointi- 
| Effects of branch treatment on the kidney and surrounding tissues
Branch treatment caused necrosis in one of eight kidneys at 7 days, although the damaged area was small and limited to the focal edge of the kidney. At 90 days, a focal damaged area was found at the edge of the kidney and identified by fibrosis, a sign of healing, in one of eight kidneys.
No elevation of serum creatinine was observed in any treated groups, indicating that renal function was unaffected. Therefore, occasional kidney damage by branch treatment may be negligible, as long as RF treatments are limited to the outside of the kidney under fluoroscopy. Adipose tissue necrosis/inflammation, which was previously reported in RF-RDN on the main RA, 20 was mainly found at 7 days in the present study. This change was not augmented in the branch RA compared with the main RA, suggesting no increased risk of branch treatment. Lesion depth was greatest at 7 days, and then reduced at later time points (because of healing) in both the main and branch RA, similar to that previously reported in RF-RDN on the main RA. 22 Lesion depth was also lower in the branch RA than that in main RA at all time points. Although the underlying mechanism remains unclear, this finding is consistent with a previous porcine study using another RF-delivering device, the Symplicity Spyral. 19 
| Biophysical parameters
Electrode temperature is determined by the balance of heat gain diffusing from tissues and heat loss by blood flow. 33 Blood flow in the branch RA is less than that in the main RA because of the smaller vessel diameter, resulting in a more rapid elevation of electrode temperature in the branch RA during RF delivery. Thus, branch treatment has the potential to produce excessive heating and subsequent unfavorable arterial damage. However, the present study showed that electrode temperature in the branch RA (66.2 C) was equivalent to that in main RA (64.2 C), and there was no increase in histopathological arterial damage in the branch RA. The equivalent electrode temperature was likely a result of the automatic control mechanism of the IberisBloom system, which decreases output power when electrode temperature reaches ≥70 C, as shown by the significantly lower terminal output power in the branch RA compared with the main RA. 25 However, impedance was higher when the electrode was located in the branch RA than in the main RA. Generally, a higher impedance relates to an increased contact force of an electrode to local tissues. 34, 35 The IberisBloom catheter has a self-expanding design, which allows the electrodes to be well apposed on the arterial wall in smaller-diameter vessels, resulting in higher impedance in the branch RA. Therefore, the IberisBloom system maintained a sufficient electrode temperature to induce protein denaturation in tissues, but without excessive heating.
| Renal norepinephrine concentration
Denervation was successfully achieved in the present study, as
shown by a significant reduction of renal norepinephrine concentration in the treated groups compared with the untreated group.
However, the reduction of renal norepinephrine concentration was less at 90 days than at 7 and 30 days. This result is in line with previous studies using healthy swine. 24, 36 Although the recovery mechanism has not yet been elucidated, previous animal studies suggest contribution of nerve regeneration. 26, 37 Considering the long-lasting effects of RDN in humans, 38 recovery of renal norepinephrine concentration as early as 3 months after RDN seems to be specific to healthy animals.
| Procedural consistency with recent clinical trials
The average number of ablations per patient varied from 14 to 45.9
among clinical studies which investigated the effect of branch FIGURE 3 Representative histopathological images of the treated main and branch RA at 7, 30, and 90 days. The images in the second-and fourth-row panels are magnified images of the boxed area in the first-and third-row panels, respectively. At 7 days, treated media was hyalinized (red-stained without smooth muscle cells) and thinned. At 30 and 90 days, treated media showed fibrosis (blue-stained fibers between cells). Thickness of the neointima (indicated as "N"), which was formed on the internal elastic lamina (dark-purple-stained fiber), was minimal at all time points. These histopathological changes were common to both the main and branch RA. Elastica Masson's trichrome staining. Scale bars: 1 mm (the first-and third-row panels; 40 μm (the second-and fourth-row panels) [Color figure can be viewed at wileyonlinelibrary.com] treatment. 8, 10, [12] [13] [14] Even considering the variation in clinical studies, the number of ablations seems to be smaller in the present study 
| Study limitations
The present study has some limitations. First, the findings obtained from the normotensive swine may not be applicable to patients with hypertension. However, the normotensive swine is the standard animal model for assessing RDN device safety, because of its anatomical and physiological similarity to humans. 7, 19, [21] [22] [23] 25, 26, 28 Second, because of the small number of animals, adverse findings with a low incidence may have been missed. Further, although the safety profile was comparable between the branch RA and main RA, there is an inherent risk of beta error with a small sample size. Third, the RDN device in the present study was applied in branch RA following the manufacturer's instruction, and thus the study result may not be transferrable to other RDN devices which are not indicated for branch RA.
| CONCLUSIONS
RF-RDN on the branch RA was safe in a porcine model, as shown by no stenotic signs and negligible kidney damage at 7, 30, and 90 days. 
